Joseph Miller
Vermogen: 10 M $ op 30-06-2026
Vermogen: 10 M $ op 30-06-2026
Joseph M.
Miller worked as Chief Financial Officer & Vice President-Finance at Eppendorf, Inc. and Eppendorf-5 Prime, Inc. from 2002 to 2006.
From 2006 to 2015, Mr. Miller was Senior Director-Accounting at Qiagen Genomics, Inc. and QIAGEN NV.
Between 2015 and 2018, Mr. Miller served as Vice President-Finance at Sucampo Pharmaceuticals LLC.
From 2020 to 2022, Mr. Miller was Director at Avalo Therapeutics, Inc. Mr. Miller's education includes an undergraduate degree from Villanova University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 02-03-2026 | 576.421 ( 0,45% ) | 10 M $ | 30-06-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Financieel Directeur/CFO | 20-03-2026 |
| AVALO THERAPEUTICS, INC. | Financieel Directeur/CFO | 24-04-2020 |
| SUCAMPO PHARMACEUTICALS, INC. | Financieel Directeur/CFO | 01-04-2018 |
Qiagen Genomics, Inc.
Qiagen Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and technology in the bioscience area | Comptroller/Controller/Auditor | 01-01-2015 |
| QIAGEN N.V. | Comptroller/Controller/Auditor | 01-01-2015 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 8 |
|---|---|
QIAGEN NV
QIAGEN NV Medical SpecialtiesHealth Technology Manufactures and distributes sample and assay technology products for pre-analytical sample preparations | Health Technology |
Eppendorf, Inc.
Eppendorf, Inc. BiotechnologyHealth Technology Manufactures bio-tech products | Health Technology |
Qiagen Genomics, Inc.
Qiagen Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and technology in the bioscience area | Commercial Services |
Villanova University
Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sucampo Pharmaceuticals LLC
Sucampo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures prostone based pharmaceuticals products | Health Technology |
Eppendorf-5 Prime, Inc. | |
Avalo Therapeutics, Inc.
Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases | Health Technology |
Aurinia Pharmaceuticals, Inc.
Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau